169 related articles for article (PubMed ID: 34533624)
41. Ginsenoside Rb3 Alleviates CSE-induced TROP2 Upregulation through p38 MAPK and NF-κB Pathways in Basal Cells.
Li H; Cui L; Liu Q; Dou S; Wang W; Xie M; Xu X; Zheng C; Li T; Huang S; Cui X; Xiao W
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):747-759. PubMed ID: 33705682
[TBL] [Abstract][Full Text] [Related]
42. The tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate in pancreatic cancer.
Mao Y; Wang X; Zheng F; Wang C; Tang Q; Tang X; Xu N; Zhang H; Zhang D; Xiong L; Liang J; Zhu J
Oncotarget; 2016 Apr; 7(17):24810-23. PubMed ID: 27050150
[TBL] [Abstract][Full Text] [Related]
43. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
[TBL] [Abstract][Full Text] [Related]
44. The oncogene Trop2 regulates fetal lung cell proliferation.
McDougall AR; Hooper SB; Zahra VA; Sozo F; Lo CY; Cole TJ; Doran T; Wallace MJ
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L478-89. PubMed ID: 21743029
[TBL] [Abstract][Full Text] [Related]
45. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
[TBL] [Abstract][Full Text] [Related]
46. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
Xu KY; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
[TBL] [Abstract][Full Text] [Related]
47. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
48. Clinical value of serum trophoblast cell surface protein 2 (TROP2) antibody in non-small-cell lung cancer patients.
Zheng Z; Dong XJ
Biomarkers; 2016 Dec; 21(8):739-742. PubMed ID: 27310709
[TBL] [Abstract][Full Text] [Related]
49. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.
Liu X; Deng J; Yuan Y; Chen W; Sun W; Wang Y; Huang H; Liang B; Ming T; Wen J; Huang B; Xing D
Pharmacol Ther; 2022 Nov; 239():108296. PubMed ID: 36208791
[TBL] [Abstract][Full Text] [Related]
50. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.
Kobayashi H; Minami Y; Anami Y; Kondou Y; Iijima T; Kano J; Morishita Y; Tsuta K; Hayashi S; Noguchi M
Virchows Arch; 2010 Jul; 457(1):69-76. PubMed ID: 20473768
[TBL] [Abstract][Full Text] [Related]
51. Development and characterization of TrMab‑6, a novel anti‑TROP2 monoclonal antibody for antigen detection in breast cancer.
Sayama Y; Kaneko MK; Kato Y
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300065
[TBL] [Abstract][Full Text] [Related]
52. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
53. Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody.
Nishimura T; Mitsunaga M; Sawada R; Saruta M; Kobayashi H; Matsumoto N; Kanke T; Yanai H; Nakamura K
Cancer Med; 2019 Dec; 8(18):7781-7792. PubMed ID: 31674732
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Han C; Perrone E; Zeybek B; Bellone S; Tymon-Rosario J; Altwerger G; Menderes G; Feinberg J; Haines K; Muller Karger ME; Bianchi A; Zammataro L; Manzano A; Bonazzoli E; Manara P; Buza N; Hui P; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Lopez S; Santin AD
Gynecol Oncol; 2020 Feb; 156(2):430-438. PubMed ID: 31839338
[TBL] [Abstract][Full Text] [Related]
55. Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
Zhang L; Yang G; Zhang R; Dong L; Chen H; Bo J; Xue W; Huang Y
Int J Oncol; 2018 Aug; 53(2):515-526. PubMed ID: 29901071
[TBL] [Abstract][Full Text] [Related]
56. Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.
Jabbarzadeh Kaboli P; Shabani S; Sharma S; Partovi Nasr M; Yamaguchi H; Hung MC
Am J Cancer Res; 2022; 12(4):1671-1685. PubMed ID: 35530278
[TBL] [Abstract][Full Text] [Related]
57. ImmunoPET imaging of Trop2 in patients with solid tumours.
Huang W; Zhang Y; Cao M; Wu Y; Jiao F; Chu Z; Zhou X; Li L; Xu D; Pan X; Guan Y; Huang G; Liu J; Xie F; Wei W
EMBO Mol Med; 2024 May; 16(5):1143-1161. PubMed ID: 38565806
[TBL] [Abstract][Full Text] [Related]
58. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.
Zhao W; Kuai X; Zhou X; Jia L; Wang J; Yang X; Tian Z; Wang X; Lv Q; Wang B; Zhao Y; Huang W
Oncol Rep; 2018 Aug; 40(2):759-766. PubMed ID: 29901160
[TBL] [Abstract][Full Text] [Related]
59. Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements.
Yao L; Chen J; Ma W
Front Oncol; 2023; 13():1292211. PubMed ID: 37954074
[TBL] [Abstract][Full Text] [Related]
60. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS
Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]